MatthewsWGwynnMD

Neurology • Atlanta, GA

Headache, Movement Disorder

President, Atlanta Neurology

Join to view full profile

Dr. Gwynn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Gwynn's full profile

Already have an account?

Office
5673 Peachtree Dunwoody Rd
Ste 300
Atlanta, GA 30342
Phone+1 404-256-3720

Fax+1 404-851-9032

Education & Training

University of Virginia Medical CenterResidency, Neurology, 1988 - 1991
University of Alabama Medical CenterResidency, Internal Medicine, 1985 - 1988
University of Virginia School of MedicineClass of 1985
College of Wiilam and MaryBS, Chemistry, 1977 - 1981

Certifications & Licensure

GA State Medical License 1991 - 2025
AZ State Medical License 2012 - 2023
FL State Medical License 2013 - 2022
KY State Medical License 2011 - 2022
NC State Medical License 2010 - 2022
VA State Medical License 1990 - 2022
IN State Medical License 2017 - 2021
SC State Medical License 2010 - 2021
TX State Medical License 2015 - 2020
AL State Medical License 1986 - 2019
TN State Medical License 2011 - 2019
American Board of Internal Medicine Internal Medicine
American Board of Psychiatry and Neurology Neurology
Association of Clinical Research ProfessionalsPrinciple Investigator-CPI
Join now to see all

Awards, Honors, & Recognition

Atlanta Magazine: Top Doctors Castle Connolly, 2000-2023
Fellow AAN American Academy of Neurology, 2019
Super Doctor SuperDoctors.com
Top MD Consumers Checkbook
Join now to see all

Clinical Trials

Extension Study of the Safety and Efficacy of Armodafinil in the Treatment of Patients With Excessive Sleepiness Start of enrollment: 2004 May 01
Completed
Phase 3
Study of the Efficacy and Multiple-Dose Plasma Concentration-Time Profiles of Armodafinil and PROVIGIL Start of enrollment: 2005 Aug 01
Completed
Phase 3
Efficacy and Safety of Armodafinil for Adults With Excessive Sleepiness Obstructive Sleep Apnea/Hypopnea and Depression Start of enrollment: 2007 Oct 01
Completed
Phase 4
Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) Start of enrollment: 2007 Dec 01
Completed
Phase 3
Efficacy and Safety Study of Adipiplon, Placebo and an Active Control in Primary Insomniacs Start of enrollment: 2008 May 01
Terminated
Phase 2
Study to Evaluate the Efficacy and Safety of Armodafinil as Treatment for Patients With Excessive Sleepiness Associated With Mild or Moderate Closed Traumatic Brain Injury Start of enrollment: 2009 Apr 30
Terminated
Phase 3
Sleep Disordered Breathing and Chronic Pain Start of enrollment: 2011 Sep 01
Completed
Not Applicable
A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness Start of enrollment: 2011 Dec 01
Completed
Phase 2
Safety and Efficacy Study of IPX159 in Restless Legs Syndrome (RLS) Start of enrollment: 2011 Nov 01
Completed
Phase 2
Open Label Extension in Adults With Binge Eating Disorder (BED) Start of enrollment: 2012 Aug 21
Completed
Phase 3
AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext Start of enrollment: 2013 Mar 01
Completed
Phase 2, Phase 3
Efficacy and Safety of DYSPORT® Using 2mL Dilution in Adults With Cervical Dystonia. Start of enrollment: 2013 Jan 01
Completed
Phase 3
Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia Start of enrollment: 2013 Mar 01
Completed
Phase 3
Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers Start of enrollment: 2013 Jul 29
Completed
Phase 3
Study of Nasal Airflow Pressure Optimization to Resolve Excessive Snoring Start of enrollment: 2013 Aug 01
Completed
Not Applicable
A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy Start of enrollment: 2014 Oct 01
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

29 citations
Improving Telestroke Treatment Times in an Expanding Network of Hospitals.
Keith A. Sanders, Rahul Patel, James M. Kiely, Matthews W. Gwynn, Lisa H. Johnston
Journal of Stroke and Cerebrovascular Diseases. 2016-02-01
5 citations
Expanding access to intravenous tissue-type plasminogen activator treatment with a practice-based telestroke system.
Keith A. Sanders, Christine Figiel, James M. Kiely, Matthews W. Gwynn, Lisa H. Johnston
Journal of Stroke and Cerebrovascular Diseases. 2013-11-01
30 citations
Tizanidine is effective in the treatment of myofascial pain syndrome.
Gerard A. Malanga, Matthews W Gwynn, Rachael Smith, Dorothy Miller
Pain Physician. 2002-10-01

Committees

Chief, Dept of Neurology--Northside Hospital Atlanta 2014 - 2015
Chairman, Dept of Internal Medicine--Northside Hospital Atlanta 2010 - 2013
Chief, Dept of Neurology-Emory St. Joseph's Hospital 2007 - 2019
Medical director, Northside Hospital Stroke Center 2005 - 2014

Professional Memberships

American Academy of Neurology - AAN
Fellow

Industry Relationships

CEO, AcuteCare TelemedicineProvide emergency neurological consultation to hospitals anywhere2009 - 2017
Owner, Atlanta Neurolegal ServicesExpert opinion consultation2010 - 2015
Medical Codirector, Neurotrials ResearchClinical research site for neurological treatments1998 - 2015
Consultant, Allergan1992 - 2014